FDA Proposes Regulating LDTs as Medical Devices, Again

Start
On October 3, the U.S. Food & Drug Administration (FDA) published a highly anticipated proposed rule (Proposed Rule) to regulate laboratory-developed tests (LDTs) as medical devices. LDTs are tests that are developed and offered by a single clinical laboratory and they make up the substantial majority of clinical laboratory testing today……
By: Bass, Berry & Sims PLC
Previous Story

Federal Circuit Patent Watch: PTAB may make implicit finding of reasonable expectation of success if arguments are intertwined with motivation to combine

Next Story

Rock Health Summit Takeaway: Digital Health is Rightsizing, Not Retreating